Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Wackel

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Annals of Thoracic Surgery|February 4, 2021
From Safety to Benefit in Cell Delivery During Surgical Repair of Ebstein Anomaly: Initial ResultsKimberly A Holst, Joseph A Dearani, M Yasir Qureshi, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 3, 2025
The American Association for Thoracic Surgery (AATS) 2025 Expert Consensus Document: Management of Ebstein anomaly in children and adults, Paul Chai, Igor E Konstantinov, et al.
Journal of Inherited Metabolic Disease|July 18, 2020
Safety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: A phase II, open-label, prospective studyMuhammad Yasir Qureshi, Marc C Patterson, Vicki Clark, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Annals of Thoracic Surgery|February 4, 2021
From Safety to Benefit in Cell Delivery During Surgical Repair of Ebstein Anomaly: Initial ResultsKimberly A Holst, Joseph A Dearani, M Yasir Qureshi, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 3, 2025
The American Association for Thoracic Surgery (AATS) 2025 Expert Consensus Document: Management of Ebstein anomaly in children and adults, Paul Chai, Igor E Konstantinov, et al.
Journal of Inherited Metabolic Disease|July 18, 2020
Safety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: A phase II, open-label, prospective studyMuhammad Yasir Qureshi, Marc C Patterson, Vicki Clark, et al.
Pageof 2